Literature DB >> 20422866

Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization.

Yoshihiro Sakamoto1, Kazuaki Shimada, Satoshi Nara, Minoru Esaki, Takahiro Kajiwara, Yasuaki Arai, Tsuyoshi Sano, Junji Yamamoto, Tomoo Kosuge.   

Abstract

BACKGROUND/AIMS: Major hepatectomy for perihilar cholangiocarcinoma has considerable risk of hepatic insufficiency even with preoperative portal vein embolization (PVE). Postoperative bilirubinemia is a great concern for hepatic surgeons.
METHODOLOGY: Between 1998 and 2004, 120 patients with hilar bile duct cancer (n = 72) and intrahepatic cholangiocarcinoma (n = 48) underwent major hepatectomies with extrahepatic biliary resection. Of these, 63 patients underwent preoperative PVE to increase the future remnant liver (FRL) volume. Risk factors for early bilirubinemia after hepatectomy (> or = 2.5 mg on day 1) were evaluated using univariate and multivariate analyses.
RESULTS: The median FRL volumes before surgery in patients with and without PVE were 46% and 70%, respectively. The serum total bilirubin (TB) value on day 1 after hepatectomy was higher in patients with PVE than in patients without PVE (2.9 mg/dL vs 1.9 mg/dL, p < 0.0001). However, the significant risk factors for higher bilirubinemia on day 1 were preoperative TB value > or = 1.0 mg/ dL (p = 0.01), blood loss > or = 1.8L (p = 0.01), and blood transfusion (p = 0.03). Two patients developed postoperative hepatic failure and one patient died of surgery from septic complication.
CONCLUSION: Major hepatectomies for perihilar cholangiocarcinoma were performed with acceptable safety using preoperative PVE. Postoperative early bilirubinemia was not associated with the FRL volume in this setting.

Entities:  

Mesh:

Year:  2010        PMID: 20422866

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  A standard definition of major hepatectomy: resection of four or more liver segments.

Authors:  Srinevas K Reddy; Andrew S Barbas; Ryan S Turley; Jennifer L Steel; Allan Tsung; J Wallis Marsh; David A Geller; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2011-07       Impact factor: 3.647

Review 2.  Epidemiology and surgical management of intrahepatic cholangiocarcinoma.

Authors:  Han Zhang; Feng Shen; Jun Han; Yi-Nan Shen; Guo-Qiang Xie; Meng-Chao Wu; Tian Yang
Journal:  Hepat Oncol       Date:  2015-11-30

Review 3.  The treatment of cholangiocarcinoma: a hepatologist's perspective.

Authors:  Kamran Qureshi; Randhir Jesudoss; Abdullah M S Al-Osaimi
Journal:  Curr Gastroenterol Rep       Date:  2014-10

4.  Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver.

Authors:  Yukinori Tanoue; Atsushi Nanashima; Koichi Yano; Yoshirou Fujii; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Makoto Ikenoue; Takashi Wada; Yoichi Mizutani; Toshinori Hirai
Journal:  Nucl Med Commun       Date:  2019-02       Impact factor: 1.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.